ZURA - Total Utang marang Modal zurabio.com

Logo perusahaan publik Zura Bio (ZURA)

Zura Bio Limited (ZURA) aims to expand its antibody portfolio to combat autoimmune pathology. A stable team of scientists and the recruitment of clinical trial experts support this strategic direction. This price trend reflected below on GURU.Markets shows a debt-to-equity ratio of 0.00. The development of orphan disease treatments and patents lay the foundation for future revenues from collaborations with industry leaders.

ZURA: Total Utang marang Modal Zura Bio 28.04.2023 - 30.10.2026

Rincian analitis perusahaan Zura Bio Limited

- rega lan prakiraan konsensus rega:
Bagan rega Zura Bio Limited|ZURA - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Zura Bio|ZURA - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Zura Bio|ZURA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku zurabio.com|ZURA - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Zura Bio Limited|ZURA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Zura Bio|ZURA - Gunggung utang perusahaan|Utang marang nilai buku Zura Bio|ZURA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Zura Bio|Likuiditas cepet zurabio.com
- informasi bathi lan kelipatan valuasi:
ZURA - Penghasilan resik
Analisis dhasar perusahaan:Zura Bio Limited
Barang utama zurabio.com

Zura Bio Limited (ZURA) investments in pipeline development and the hiring of clinical experts require precise liquidity management. The total debt-to-equity ratio compares external obligations to equity, measuring the degree of financial leverage. An increase in this metric on the chart signals a rising debt load relative to net assets. Stable price action confirms a balanced financing structure, which ensures the sustainability of the company's market valuation.

Analisis pesaing Zura Bio Limited

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA: Rasio Total Utang marang Ekuitas|Utang Agregat marang Ekuitas SVRA|RIGL (Rigel Pharmaceuticals) - Rasio Total Utang marang Ekuitas|anaptysbio.com (ANAB) - Total Utang marang Modal|Utang marang Ekuitas Astria Therapeutics, Inc.|ENGN: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal RAPT|Total Utang marang Modal aerovatetx.com (JBIO)|Aclaris Therapeutics - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi KYTX|Tiziana Life Sciences Ltd - Total Utang marang Modal|CABA: Utang marang Ekuitas|VTYX: Total Utang marang Modal|THTX - Koefisien Total Utang marang Modal|Utang marang Ekuitas Avalo Therapeutics, Inc|Utang marang Modal eledon.com ELDN|Rasio Total Utang marang Ekuitas AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas aTyr ATYR|Adagene Inc - Utang marang Ekuitas|Ikena Oncology, Inc. - Total Utang marang Modal|Koefisien Total Utang marang Modal Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Connect Biopharma Holdings Limited|IMUX (Immunic Therapeutics) - Total Utang marang Modal|Atara Biotherapeutics Inc (ATRA) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas IFRX (InflaRx N.V.)|Utang Agregat marang Modal XFOR|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Utang marang Modal|INmune Bio Corp - Total Utang marang Modal|BRNS (Barinthus Biotherapeutics Corp) - Rasio Utang marang Ekuitas|KZR (Kezar Life Sciences) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Ekuitas SABS (sabbiotherapeutics.com)|Rasio Total Utang marang Ekuitas AKTX|Total Utang marang Modal Enlivex Therapeutics, Ltd.|Utang marang Ekuitas Q32 Bio Inc. (QTTB)|GOVX (GeoVax Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal EDSA (Edesa Biotech, Inc.)|Total Utang marang Modal ibioinc.com IBIO|CARM - Utang marang Ekuitas|Utang Agregat marang Ekuitas XTLB|BOLT: Total Utang marang Modal|HCW Biologics - Rasio Kabeh Utang marang Dana Pribadi|APVO (Aptevo Therapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal AIM ImmunoTech, Inc.|Utang marang Ekuitas Aditxt (ADTX)|GRI (GRI Bio Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas XORTX XRTX|HIND - Rasio Total Utang marang Ekuitas|Revelation Biosciences - Total Utang marang Modal|INDP - Total Utang marang Modal|SCNI (Scinai Immunotherapeutics Ltd.) - Rasio Total Utang marang Ekuitas|CalciMedica - Rasio Kabeh Utang marang Dana Pribadi|AFMD (Affimed NV) - Total Utang marang Modal|Allakos Therapeutics (ALLK) - Koefisien Total Utang marang Modal|Utang marang Ekuitas HOOKIPA Pharma Inc. (HOOK)|Rasio Total Utang marang Ekuitas igmbio.com IGMS|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|OCEA - Rasio Total Utang marang Ekuitas|TCBP: Rasio Total Utang marang Ekuitas|THRD - Total Utang marang Modal